Executive summary of the consensus document on metabolic disorders and cardiovascular risk in patients with HIV infection

Autors de IIS La Fe

• María Jose Galindo Puerto

  Autor

• Vicenta Asensi Gimeno

  Autor

• José López Aldeguer

  Autor

• Fernando Lozano

  Autor

Autors aliens a IIS La Fe

• Panel of experts from the Metabolic Disorders Study Group (GEAM), National Aids
• Polo Rodríguez R
• Dueñas C
• Gómez Candela C
• Estrada V
• Villar NG
• Locutura J
• Mariño A
• Pascua J
• Palacios R
• Von Wichmman MÁ
• Álvarez J
• Negredo E
• Ortega E
• Pedrol E
• Gutiérrez F
• Sanz Sanz J
• Martínez Chamorro E

Grups d'Investigació

• Investigacion clínica en enfermedades crónicas e Infección por el VIH

  Investigador establecido

  Marta Montero Alonso

Abstract

The importance of the metabolic disorders and their impact on patients with HIV infection requires an individualized study and continuous updating. HIV patients have the same cardiovascular risk factors as the general population. The HIV infection per se increases the cardiovascular risk, and metabolic disorders caused by some antiretroviral drugs are added risk factors. For this reason, the choice of drugs with a good metabolic profile is essential. The most common metabolic disorders of HIV infected-patients (insulin resistance, diabetes, hyperlipidemia or osteopenia), as well as other factors of cardiovascular risk, such as hypertension, should also be dealt with according to guidelines similar to the general population, as well as insisting on steps to healthier lifestyles. The aim of this document is to provide a query tool for all professionals who treat HIV-patients and who may present or display any metabolic disorders listed in this document. (C) 2014 Elsevier Espana, S.L.U. and Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica. All rights reserved.

Keywords

• HIV infection; Metabolic disorders; Cardiovascular risk